We are live on
!
Find out more
AAP
Ardsley Advisory Partners Portfolio holdings
AUM
$960M
1-Year Est. Return
207.76%
This Fund
S&P 500
This Quarter
Est. Return
+62.68%
1 Year Est. Return
+207.76%
3 Year Est. Return
+554.53%
5 Year Est. Return
+728.66%
10 Year Est. Return
+4,084.52%
AUM
$470M
AUM Growth
+$215M
(+84%)
Cap. Flow
+$84.2M
Cap. Flow
% of AUM
17.91%
Top 10 Holdings %
Top 10 Hldgs %
50.14%
Holding
180
New
79
Increased
20
Reduced
20
Closed
47
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$19.9M |
| 2 |
T-Mobile US
TMUS
|
+$17.2M |
| 3 |
AbbVie
ABBV
|
+$12.5M |
| 4 |
Lumentum
LITE
|
+$11.5M |
| 5 |
Qualcomm
QCOM
|
+$10.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$8.88M |
| 2 |
FTAI Aviation
FTAI
|
+$8.81M |
| 3 |
STAAR Surgical
STAA
|
+$8.17M |
| 4 |
Sunrun
RUN
|
+$6.51M |
| 5 |
ZEN
ZENDESK INC
ZEN
|
+$6.08M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.99% |
| 2 | Healthcare | 17.02% |
| 3 | Consumer Staples | 13.31% |
| 4 | Industrials | 11.19% |
| 5 | Consumer Discretionary | 7.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BFYT
51
PUT
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
| $1.21M | 0.26% |
+59,000
| New | +$1.25M |
|
52
Wayfair
W
$12.5B
| $1.19M | 0.25% |
+6,000
| New | +$897K |
|
53
RingCentral
RNG
$4.77B
| $1.14M | 0.24% |
+4,000
| New | +$1.01M |
|
|
API
54
Agora
API
$333M
| $1.1M | 0.23% |
+25,000
| New | +$1.18M |
|
|
AMRS
55
DELISTED
Amyris Inc.
AMRS
| $1.08M | 0.23% |
253,700
+25,000
| +11% | +$83.1K |
|
56
Workday
WDAY
$39.4B
| $1.03M | 0.22% |
+5,500
| New | +$889K |
|
57
ServiceNow
NOW
$114B
| $1.01M | 0.22% |
12,500
-2,500
| -17% | -$177K |
|
|
58
CALL
Wayfair
W
$12.5B
| $988K | 0.21% |
+5,000
| New | +$748K |
|
|
TLND
59
DELISTED
Talend S.A. American Depositary Shares
TLND
| $953K | 0.2% |
+27,500
| New | +$810K |
|
|
ITI
60
DELISTED
Iteris, Inc.
ITI
| $951K | 0.2% |
200,000
-100,000
| -33% | -$417K |
|
61
Dell
DELL
$253B
| $907K | 0.19% |
+32,555
| New | +$731K |
|
62
Vertex Pharmaceuticals
VRTX
$124B
| $871K | 0.19% |
3,000
-2,000
| -40% | -$542K |
|
63
Zillow
Z
$7.7B
| $864K | 0.18% |
+15,000
| New | +$745K |
|
64
Baxter International
BAX
$12.6B
| $861K | 0.18% |
10,000
-900
| -8% | -$78.4K |
|
65
Labcorp
LH
$25.8B
| $831K | 0.18% |
+5,820
| New | +$805K |
|
66
Alta Equipment Group
ALTG
$207M
| $818K | 0.17% |
105,263
| – | – |
|
67
Jazz Pharmaceuticals
JAZZ
$16.1B
| $772K | 0.16% |
+7,000
| New | +$774K |
|
68
AstraZeneca
AZN
$267B
| $767K | 0.16% |
+7,250
| New | +$749K |
|
69
UnitedHealth
UNH
$389B
| $737K | 0.16% |
2,500
| – | – |
|
70
Encompass Health
EHC
$11.5B
| $681K | 0.14% |
13,827
+7,542
| +120% | +$407K |
|
71
Nokia
NOK
$49.9B
| $678K | 0.14% |
+154,000
| New | +$582K |
|
72
Applied Materials
AMAT
$378B
| $665K | 0.14% |
+11,000
| New | +$593K |
|
|
SPLK
73
DELISTED
Splunk Inc
SPLK
| $646K | 0.14% |
+3,250
| New | +$514K |
|
74
Centene
CNC
$31.6B
| $636K | 0.14% |
+10,000
| New | +$651K |
|
75
Zimmer Biomet
ZBH
$18.5B
| $597K | 0.13% |
+5,150
| New | +$593K |
|
Similar funds
NA
MK
QIM
JVBC
TFP
UWPG
LOAMU
PHS
Ardsley Advisory Partners's Q2 2020 Portfolio in Review
As of Q2 2020, Ardsley Advisory Partners held 180 positions worth $470M, up 84% from $255M the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Ardsley Advisory Partners deployed $84.2M of net new capital in Q2 2020, opening 79 new positions and adding to 20 existing holdings. Its largest new stake was T-Mobile US: 179,510 shares worth $18.7M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Staples.
On the sell side, the largest reduction was State Street SPDR S&P Biotech ETF, an estimated $8.88M trimmed.
- Ardsley Advisory Partners's largest Q2 2020 buy was T-Mobile US: 179,510 shares worth $18.7M.
- Ardsley Advisory Partners added most to Microsoft in Q2 2020, an estimated $19.9M increase.
- Ardsley Advisory Partners's biggest Q2 2020 reduction was State Street SPDR S&P Biotech ETF, cutting an estimated $8.88M.
- Ardsley Advisory Partners fully exited ZENDESK INC in Q2 2020, selling an estimated $6.08M.
- Ardsley Advisory Partners's ten largest holdings make up 50% of its $470M portfolio in Q2 2020.
- Ardsley Advisory Partners opened 79 new positions and closed 47 in Q2 2020.
- Ardsley Advisory Partners's portfolio value rose 84% quarter-over-quarter to $470M.
Based on Ardsley Advisory Partners's 13F filing for Q2 2020, filed 14 Aug 2020.